Deutsche Bank downgraded Amedisys (NASDAQ: AMED) from Hold to Sell with a price target of $8.00 (from $11.00). Analyst Darren ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE